Schedule 13G ownership disclosure

TRAWS PHARMA INC

Common stock, par value $.01 per share · CUSIP: 68232V884

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ikarian Capital, LLC

    Shares: 812,524 · Class: 9.99%

  • Neil Shahrestani

    Shares: 812,524 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-055077
Form type
SCHEDULE 13G/A
Filer
Ikarian Capital, LLC
CIK
CIK 1778253
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub